Cargando…

Correction to: New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases

Detalles Bibliográficos
Autores principales:	Assini, Andrea, Benedetti, Luana, Di Maio, Silvia, Schirinzi, Erika, Del Sette, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2020
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7279431/ https://www.ncbi.nlm.nih.gov/pubmed/32514856 http://dx.doi.org/10.1007/s10072-020-04517-z

Ejemplares similares

New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases
por: Assini, Andrea, et al.
Publicado: (2020)

The importance of thinking about Guillain-Barré syndrome during the COVID-19 pandemic: a case with pure dysautonomic presentation
por: Biassoni, Erica, et al.
Publicado: (2021)

Give or take? Intravenous immunoglobulin or plasma exchange for Guillain-Barré syndrome
por: Hughes, Richard AC
Publicado: (2011)

Intravenous immunoglobulins versus plasma exchange in the treatment of Guillain-Barré syndrome
por: Charra, B, et al.
Publicado: (2009)

Intravenous immunoglobulin in COVID-19 associated Guillain–Barré syndrome in pregnancy
por: Garcia, Jao Jarro, et al.
Publicado: (2021)

Correction to: Guidelines for Neuroprognostication in Adults with Guillain–Barré Syndrome
por: Busl, Katharina M., et al.
Publicado: (2023)

COVID-19-related and not related Guillain-Barré syndromes share the same management pitfalls during lock down: The experience of Liguria region in Italy
por: Garnero, Martina, et al.
Publicado: (2020)

Acute aseptic meningitis due to intravenous immunoglobulin therapy in Guillain–Barré syndrome
por: Jain, Rajendra Singh, et al.
Publicado: (2014)

Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study
por: Verboon, Christine, et al.
Publicado: (2021)

Population Pharmacokinetic Modelling of Intravenous Immunoglobulin Treatment in Patients with Guillain–Barré Syndrome
por: Fokkink, Willem Jan R., et al.
Publicado: (2022)

Author Correction: Guidelines for Neuroprognostication in Adults with Guillain–Barré Syndrome
por: Busl, Katharina M., et al.
Publicado: (2023)

Prominent Plasmacytosis Following Intravenous Immunoglobulin Correlates with Clinical Improvement in Guillain-Barré Syndrome
por: Mori, Izumi, et al.
Publicado: (2008)

Intravenous Immunoglobulin for Severe Protracted Pediatric Guillain–Barre Syndrome: Is Single Dose Adequate?
por: Madaan, Priyanka, et al.
Publicado: (2019)

Reversible posterior encephalopathy syndrome due to intravenous immunoglobulin in a child with Guillain-Barré syndrome
por: Incecik, Faruk, et al.
Publicado: (2011)

Intravenous immunoglobulin vs plasma exchange in treatment of mechanically ventilated adults with Guillain-Barré syndrome
por: Charra, Boubaker, et al.
Publicado: (2014)

Intravenous Immunoglobulin may Reverse Multisystem Inflammation in COVID-19 Pneumonitis and Guillain–Barré Syndrome
por: Chakraborty, Nilanchal, et al.
Publicado: (2020)

Correction to: Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports
por: Rahimi, Kaveh
Publicado: (2020)

Asymptomatic peripheral neuropathy in patients with SARS-CoV-2 infection
por: Schirinzi, Erika, et al.
Publicado: (2021)

Correction to: COVID‑19‑associated Guillain‑Barré syndrome in the early pandemic experience in Lombardia (Italy)
por: Martinelli‑Boneschi, Filippo, et al.
Publicado: (2022)

Immunoglobulin and Monoclonal Antibody Therapies in Guillain-Barré Syndrome
por: Rajabally, Yusuf A.
Publicado: (2022)

Treatment related fluctuation and response to intravenous immunoglobulin therapy in post COVID-19 Guillain-Barre syndrome()
por: Gupta, Subhadeep, et al.
Publicado: (2021)

Intravenous immunoglobulin treatment with prognosis for the first six months of Guillain–Barré Syndrome in Somalia: Case series
por: Sidow, Nor Osman, et al.
Publicado: (2022)

Impact of quarantine due to COVID infection on migraine: a survey in Genova, Italy
por: Parodi, Italo Carlo, et al.
Publicado: (2020)

Correction to: Guillain–Barre syndrome after myocardial infarction: a case report and literature review
por: Wen, Pu-yuan, et al.
Publicado: (2023)

Guillain Barre syndrome as a manifestation of neurological melioidosis
por: Krovvidi, Rajesh, et al.
Publicado: (2013)

Comparison of intravenous immunoglobulin and plasma exchange in treatment of mechanically ventilated children with Guillain Barré syndrome: a randomized study
por: El-Bayoumi, Mohammed A, et al.
Publicado: (2011)

Changes in lymphocyte subsets in patients with Guillain-Barré syndrome treated with immunoglobulin
por: Hou, Hui Qing, et al.
Publicado: (2014)

Orthopaedic manifestations and diagnostic clues in children with Guillain–Barré syndrome
por: Matsushita, Masaki, et al.
Publicado: (2013)

Cardiogenic Shock and Guillain–Barré Syndrome as the First Manifestations of Pheochromocytoma
por: Heidarpour, Maryam, et al.
Publicado: (2021)

Guillain-Barré syndrome as only manifestation of COVID-19 infection
por: d’Orsi, Giuseppe, et al.
Publicado: (2021)

Guillain–Barré syndrome
por: Mirian, Ario, et al.
Publicado: (2021)

COVID-19 vaccination and Guillain-Barré syndrome: analyses using the National Immunoglobulin Database
por: Keh, Ryan Y S, et al.
Publicado: (2022)

Publisher Correction: A Simplified, Graded, Electrodiagnostic Criterion for Guillain-Barré Syndrome That Incorporates Sensory Nerve Conduction Studies
por: Umapathi, Thirugnanam, et al.
Publicado: (2020)

Guillain–Barré syndrome as the first manifestation of SARS-CoV-2 infection
por: Barrachina-Esteve, O., et al.
Publicado: (2020)

Clinical Characteristics of Intravenous Injection of Monosialotetrahexosyl Ganglioside Sodium-Related Guillain-Barre Syndrome
por: Shi, Miao, et al.
Publicado: (2019)

Correlations between microRNA-146a and immunoglobulin and inflammatory factors in Guillain–Barré syndrome
por: Huang, Pan, et al.
Publicado: (2020)

Severe Acute Kidney Injury Secondary to Immunoglobulin Infusion in Life-Threatening Guillain Barre Syndrome
por: Orquera, José David, et al.
Publicado: (2022)

Correction: Optimal Attenuation of Experimental Autoimmune Encephalomyelitis by Intravenous Immunoglobulin Requires an Intact Interleukin-11 Receptor
Publicado: (2014)

Guillain-Barré Syndrome, Before and After Zika
por: Del Carpio-Orantes, Luis, et al.
Publicado: (2019)

Hyperreflexic Guillain-Barré syndrome
por: Baheti, Neeraj N., et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_634kq81jia6ghpnkf8hani9bfc